SlideShare ist ein Scribd-Unternehmen logo
1 von 22
Pentose Phosphate Pathway Generation of NADPH and Pentoses
Overview Function NADPH production Reducing power carrier Synthetic pathways Role as cellular antioxidants Ribose synthesis Nucleic acids and nucleotides
Characteristics:Tissue Distribution Demand for NADPH Biosynthetic pathways FA synthesis (liver, adipose, mammary) Cholesterol synthesis (liver) Steroid hormone synthesis (adrenal, ovaries, testes) Detoxification (Cytochrome P-450 System) – liver Reduced glutathione as an antioxidant (RBC) Generation of superoxide (neutrophils)
Characteristics:Oxidative and Non-oxidative Phases Oxidative phases Reactions producing NADPH Irreversible  Non-oxidative phases Produces ribose-5-P Reversible reactions feed to glycolysis
NADPH producing reactions Glucose-6-P dehydrogenase 6-P-gluconate dehydrogenase
The Pentose Phosphate Pathway:Non-oxidative phases
Regulation Glucose-6-P dehydrogenase First step Rate limiting Allosteric Regulation Feedback inhibited by NADPH Inducible enzyme Induced by insulin
Role of NADPH in the RBC Production of superoxide Hb-Fe2+-O2 -> Hb-Fe3+ + O2-. Spontaneous rxn, 1% per hour O2-. + 2H2O -> 2H2O2 Both O2-.  & H2O2 can produce reactive free radical species, damage cell membranes, and cause hemolysis
Detoxification of Superoxide Anion and Hydrogen Peroxide Antioxidant enzymes Superoxide dismutase Glutathione peroxidase Glutathione reductase
Case Study 21 yo male medical student with malaria Treated with primaquine Four days later: Black colored urine Low RBC count Elevated reticulocyte count RBC with Heinz bodies Low hemoglobin Elevated serum bilirubin Pt recovered in a few days
G6PDH Deficiency and Hemolytic Anemia Most common genetic enzymopathy  400 hundred variants of G6PDH deficiency Mediterranean, Asian, African descent 400 million people affected worldwide 50% of Kurdish men 10-14% of African-American men with G6PD deficiency
Worldwide distribution of G6PD deficiency: 1995
G6PD Deficiency Distribution of G6PD deficiency coincides prevalence of malaria G6PD deficiency may impart some degree of malaria resistance Also sickle cell anemia
Genetics Recessive sex-linked mutation X-chromosome Rare in females (two X-chromosomes) Homozygous mutation:  high hemolysis and anemia Heterozygous mutation:  Normally asymptomatic  unless exposed to drugs (primaquine, anti-malarial drug) or compounds (fava bean) that produce superoxide or hydrogen peroxide
Inheritance of G6PD Deficiency
G6PD Deficiency Exposure to anti-malarial drugs (Primaquine) results in increased cellular production of superoxide and hydrogen peroxide (Primaquine sensitivity) Other chemicals known to increase oxidant stress Sulfonamides (antibiotic) Asprin and NSAIDs Quinadine and quinine Napthlane (mothballs) Fava beans (vicine & isouramil)
Fava Beans Grown worldwide Important in Middle East High in protein Frost resistant perennial Genetically modified fava bean being developed Low in vicine and isouramil Favism
Case Study 21 yo male medical student with malaria Treated with primaquine Four days later: Black colored urine Low RBC count Elevated reticulocyte count RBC with Heinz bodies Low hemoglobin Elevated serum bilirubin Pt recovered in a few days
Symptoms  Black colored urine Hemolysis may result in urinary excretion of hemoglobin Low RBC count & low hemoglobin Result of high rate of hemolysis Elevated bilirubin Catabolism of heme
RBCs with Heinz Bodies Precipitation of hemoglobin due to disulfide bond formation between Hb molecues Upper photo shows distorted RBCs with large Heinz bodies Bottom photo shows RBC stained with methylene blue
Elevated Reticulocytes A RBC containing granules or filaments representing an immature stage in cell development Normally constitutes 1% of circulating RBCs Reticulocytosis Elevation of reticulocytes Indicative of active erthropoiesis in red bone marrow
Defective G6PDH Results in enzyme with unstable structure Patient with 10% of normal activity Enough to generate NADPH under normal condition Newly made RBCs have normal 6PDH activity Patients recover quickly (8 days)

Weitere Àhnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

PYRIMIDINE SYNTHESIS
PYRIMIDINE SYNTHESISPYRIMIDINE SYNTHESIS
PYRIMIDINE SYNTHESIS
 
Cholesterol biosynthesis final
Cholesterol biosynthesis finalCholesterol biosynthesis final
Cholesterol biosynthesis final
 
Biosynthesis of glycerides, phospholipids and cholesterol
Biosynthesis of glycerides, phospholipids and cholesterolBiosynthesis of glycerides, phospholipids and cholesterol
Biosynthesis of glycerides, phospholipids and cholesterol
 
De novo and salvage pathway of nucleotides synthesis.pptx
De novo and salvage pathway of nucleotides synthesis.pptxDe novo and salvage pathway of nucleotides synthesis.pptx
De novo and salvage pathway of nucleotides synthesis.pptx
 
Amino acid catabolism- Part-1
Amino acid catabolism- Part-1Amino acid catabolism- Part-1
Amino acid catabolism- Part-1
 
Gluconeogenesis
GluconeogenesisGluconeogenesis
Gluconeogenesis
 
BIOSYNTHESIS OF FATTY ACIDS
BIOSYNTHESIS OF FATTY ACIDSBIOSYNTHESIS OF FATTY ACIDS
BIOSYNTHESIS OF FATTY ACIDS
 
Fatty acid synthesis
Fatty acid synthesis Fatty acid synthesis
Fatty acid synthesis
 
Glycolysis ppt
Glycolysis pptGlycolysis ppt
Glycolysis ppt
 
Biosynthesis of Phospholipids
Biosynthesis of PhospholipidsBiosynthesis of Phospholipids
Biosynthesis of Phospholipids
 
Amino acid metabolism
Amino acid metabolismAmino acid metabolism
Amino acid metabolism
 
Cholesterol Biosynthesis
Cholesterol BiosynthesisCholesterol Biosynthesis
Cholesterol Biosynthesis
 
Pyrimidine Synthesis and Degradation
Pyrimidine Synthesis and DegradationPyrimidine Synthesis and Degradation
Pyrimidine Synthesis and Degradation
 
Fatty acid synthesis
Fatty acid synthesisFatty acid synthesis
Fatty acid synthesis
 
Nucleotide metabolism
Nucleotide metabolism Nucleotide metabolism
Nucleotide metabolism
 
Amino acid metabolism
Amino acid metabolismAmino acid metabolism
Amino acid metabolism
 
Cholesterol metabolism
Cholesterol metabolismCholesterol metabolism
Cholesterol metabolism
 
HMP Shunt & Uronic Acid PAthway
HMP Shunt & Uronic Acid PAthwayHMP Shunt & Uronic Acid PAthway
HMP Shunt & Uronic Acid PAthway
 
PPP, Glucuronate Pathway & Lactose Synthesis
PPP, Glucuronate Pathway & Lactose SynthesisPPP, Glucuronate Pathway & Lactose Synthesis
PPP, Glucuronate Pathway & Lactose Synthesis
 
BIOSYNTHESIS OF PURINE NUCLEOTIDES
BIOSYNTHESIS OF PURINE NUCLEOTIDESBIOSYNTHESIS OF PURINE NUCLEOTIDES
BIOSYNTHESIS OF PURINE NUCLEOTIDES
 

Andere mochten auch

Inflammation acute and chronic
Inflammation acute and chronicInflammation acute and chronic
Inflammation acute and chronic
userzain
 
Urea cycle
Urea cycleUrea cycle
Urea cycle
Edna Peter
 

Andere mochten auch (20)

Glycogenolysis
GlycogenolysisGlycogenolysis
Glycogenolysis
 
POLYAMINES
POLYAMINESPOLYAMINES
POLYAMINES
 
Urea cycle and its disorders
Urea cycle and its disordersUrea cycle and its disorders
Urea cycle and its disorders
 
Polyamines
PolyaminesPolyamines
Polyamines
 
Inflammation acute and chronic
Inflammation acute and chronicInflammation acute and chronic
Inflammation acute and chronic
 
Biosynthesis of nucleotides
Biosynthesis of nucleotidesBiosynthesis of nucleotides
Biosynthesis of nucleotides
 
De novo and salvage pathway of purines
De novo and salvage pathway of purinesDe novo and salvage pathway of purines
De novo and salvage pathway of purines
 
TRANSDEAMINATION AND DEAMINATION
TRANSDEAMINATION AND DEAMINATIONTRANSDEAMINATION AND DEAMINATION
TRANSDEAMINATION AND DEAMINATION
 
ENZYMES
ENZYMESENZYMES
ENZYMES
 
Transamination & deamination
Transamination & deaminationTransamination & deamination
Transamination & deamination
 
Amino Acids metabolism
Amino Acids metabolismAmino Acids metabolism
Amino Acids metabolism
 
Purine & pyrimidine metabolism and disorders
Purine & pyrimidine metabolism and disordersPurine & pyrimidine metabolism and disorders
Purine & pyrimidine metabolism and disorders
 
Amino acids metabolism new
Amino acids metabolism newAmino acids metabolism new
Amino acids metabolism new
 
Urea cycle
Urea cycleUrea cycle
Urea cycle
 
Amino acid catabolism - Part-2 (Urea cycle and clinical significance)
Amino acid catabolism - Part-2 (Urea cycle and clinical significance)Amino acid catabolism - Part-2 (Urea cycle and clinical significance)
Amino acid catabolism - Part-2 (Urea cycle and clinical significance)
 
UREA CYCLE
UREA CYCLEUREA CYCLE
UREA CYCLE
 
De Novo synthesis of fatty acids
De Novo synthesis of fatty acidsDe Novo synthesis of fatty acids
De Novo synthesis of fatty acids
 
TRANSAMINATION & DEAMINATION
TRANSAMINATION & DEAMINATIONTRANSAMINATION & DEAMINATION
TRANSAMINATION & DEAMINATION
 
Metabolism of nucleotides new
Metabolism of nucleotides newMetabolism of nucleotides new
Metabolism of nucleotides new
 
Lipoproteins
LipoproteinsLipoproteins
Lipoproteins
 

Ähnlich wie Pentose Phosphate Pathway

Pentose phosphate pathway
Pentose phosphate pathwayPentose phosphate pathway
Pentose phosphate pathway
Prince Adoba
 
Purine and Pyrimidine Metabolism.pptx
Purine and Pyrimidine Metabolism.pptxPurine and Pyrimidine Metabolism.pptx
Purine and Pyrimidine Metabolism.pptx
karthikeyan104187
 

Ähnlich wie Pentose Phosphate Pathway (20)

Pentose phosphate pathway
Pentose phosphate pathwayPentose phosphate pathway
Pentose phosphate pathway
 
Pentosephosphatepathway 090709012632-phpapp02
Pentosephosphatepathway 090709012632-phpapp02Pentosephosphatepathway 090709012632-phpapp02
Pentosephosphatepathway 090709012632-phpapp02
 
2.2 pentose and uronic pathway.pptx
2.2 pentose and uronic pathway.pptx2.2 pentose and uronic pathway.pptx
2.2 pentose and uronic pathway.pptx
 
metab. of nucleotide 1.pptx
metab. of nucleotide 1.pptxmetab. of nucleotide 1.pptx
metab. of nucleotide 1.pptx
 
03 g6 pd deficiency
03 g6 pd deficiency03 g6 pd deficiency
03 g6 pd deficiency
 
Hmp shunt
Hmp shuntHmp shunt
Hmp shunt
 
Purine and Pyrimidine Metabolism.pptx
Purine and Pyrimidine Metabolism.pptxPurine and Pyrimidine Metabolism.pptx
Purine and Pyrimidine Metabolism.pptx
 
Hexose monophosphate pathway/Pentose phosphate pathway.pptx
Hexose monophosphate pathway/Pentose phosphate pathway.pptxHexose monophosphate pathway/Pentose phosphate pathway.pptx
Hexose monophosphate pathway/Pentose phosphate pathway.pptx
 
Class 2 3 glycolysis
Class 2 3 glycolysisClass 2 3 glycolysis
Class 2 3 glycolysis
 
Biochemistry high yield part 2
Biochemistry high yield part 2Biochemistry high yield part 2
Biochemistry high yield part 2
 
The pentose phosphate pathway
The pentose phosphate pathwayThe pentose phosphate pathway
The pentose phosphate pathway
 
Disorders of carbohydrate metabolism
Disorders of carbohydrate metabolismDisorders of carbohydrate metabolism
Disorders of carbohydrate metabolism
 
Pentose phostphate pathway.ppt
Pentose phostphate pathway.pptPentose phostphate pathway.ppt
Pentose phostphate pathway.ppt
 
purine metabolism.ppt
purine metabolism.pptpurine metabolism.ppt
purine metabolism.ppt
 
Class 2 glycolysis
Class 2  glycolysisClass 2  glycolysis
Class 2 glycolysis
 
G6PD disease.pptx
G6PD disease.pptxG6PD disease.pptx
G6PD disease.pptx
 
PURINE METABOLISM LECTURE.ppt
PURINE METABOLISM LECTURE.pptPURINE METABOLISM LECTURE.ppt
PURINE METABOLISM LECTURE.ppt
 
Glycolysis 2nd year MBBS 2024.pdf
Glycolysis 2nd year MBBS  2024.pdfGlycolysis 2nd year MBBS  2024.pdf
Glycolysis 2nd year MBBS 2024.pdf
 
glucagon disorder
glucagon disorder glucagon disorder
glucagon disorder
 
Porphyria
Porphyria Porphyria
Porphyria
 

KĂŒrzlich hochgeladen

Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
Joaquim Jorge
 

KĂŒrzlich hochgeladen (20)

Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 
Tech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdfTech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdf
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
 
🐬 The future of MySQL is Postgres 🐘
🐬  The future of MySQL is Postgres   🐘🐬  The future of MySQL is Postgres   🐘
🐬 The future of MySQL is Postgres 🐘
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024
 
Handwritten Text Recognition for manuscripts and early printed texts
Handwritten Text Recognition for manuscripts and early printed textsHandwritten Text Recognition for manuscripts and early printed texts
Handwritten Text Recognition for manuscripts and early printed texts
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
 
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 

Pentose Phosphate Pathway

  • 1. Pentose Phosphate Pathway Generation of NADPH and Pentoses
  • 2. Overview Function NADPH production Reducing power carrier Synthetic pathways Role as cellular antioxidants Ribose synthesis Nucleic acids and nucleotides
  • 3. Characteristics:Tissue Distribution Demand for NADPH Biosynthetic pathways FA synthesis (liver, adipose, mammary) Cholesterol synthesis (liver) Steroid hormone synthesis (adrenal, ovaries, testes) Detoxification (Cytochrome P-450 System) – liver Reduced glutathione as an antioxidant (RBC) Generation of superoxide (neutrophils)
  • 4. Characteristics:Oxidative and Non-oxidative Phases Oxidative phases Reactions producing NADPH Irreversible Non-oxidative phases Produces ribose-5-P Reversible reactions feed to glycolysis
  • 5. NADPH producing reactions Glucose-6-P dehydrogenase 6-P-gluconate dehydrogenase
  • 6. The Pentose Phosphate Pathway:Non-oxidative phases
  • 7. Regulation Glucose-6-P dehydrogenase First step Rate limiting Allosteric Regulation Feedback inhibited by NADPH Inducible enzyme Induced by insulin
  • 8. Role of NADPH in the RBC Production of superoxide Hb-Fe2+-O2 -> Hb-Fe3+ + O2-. Spontaneous rxn, 1% per hour O2-. + 2H2O -> 2H2O2 Both O2-. & H2O2 can produce reactive free radical species, damage cell membranes, and cause hemolysis
  • 9. Detoxification of Superoxide Anion and Hydrogen Peroxide Antioxidant enzymes Superoxide dismutase Glutathione peroxidase Glutathione reductase
  • 10. Case Study 21 yo male medical student with malaria Treated with primaquine Four days later: Black colored urine Low RBC count Elevated reticulocyte count RBC with Heinz bodies Low hemoglobin Elevated serum bilirubin Pt recovered in a few days
  • 11. G6PDH Deficiency and Hemolytic Anemia Most common genetic enzymopathy 400 hundred variants of G6PDH deficiency Mediterranean, Asian, African descent 400 million people affected worldwide 50% of Kurdish men 10-14% of African-American men with G6PD deficiency
  • 12. Worldwide distribution of G6PD deficiency: 1995
  • 13. G6PD Deficiency Distribution of G6PD deficiency coincides prevalence of malaria G6PD deficiency may impart some degree of malaria resistance Also sickle cell anemia
  • 14. Genetics Recessive sex-linked mutation X-chromosome Rare in females (two X-chromosomes) Homozygous mutation: high hemolysis and anemia Heterozygous mutation: Normally asymptomatic unless exposed to drugs (primaquine, anti-malarial drug) or compounds (fava bean) that produce superoxide or hydrogen peroxide
  • 15. Inheritance of G6PD Deficiency
  • 16. G6PD Deficiency Exposure to anti-malarial drugs (Primaquine) results in increased cellular production of superoxide and hydrogen peroxide (Primaquine sensitivity) Other chemicals known to increase oxidant stress Sulfonamides (antibiotic) Asprin and NSAIDs Quinadine and quinine Napthlane (mothballs) Fava beans (vicine & isouramil)
  • 17. Fava Beans Grown worldwide Important in Middle East High in protein Frost resistant perennial Genetically modified fava bean being developed Low in vicine and isouramil Favism
  • 18. Case Study 21 yo male medical student with malaria Treated with primaquine Four days later: Black colored urine Low RBC count Elevated reticulocyte count RBC with Heinz bodies Low hemoglobin Elevated serum bilirubin Pt recovered in a few days
  • 19. Symptoms Black colored urine Hemolysis may result in urinary excretion of hemoglobin Low RBC count & low hemoglobin Result of high rate of hemolysis Elevated bilirubin Catabolism of heme
  • 20. RBCs with Heinz Bodies Precipitation of hemoglobin due to disulfide bond formation between Hb molecues Upper photo shows distorted RBCs with large Heinz bodies Bottom photo shows RBC stained with methylene blue
  • 21. Elevated Reticulocytes A RBC containing granules or filaments representing an immature stage in cell development Normally constitutes 1% of circulating RBCs Reticulocytosis Elevation of reticulocytes Indicative of active erthropoiesis in red bone marrow
  • 22. Defective G6PDH Results in enzyme with unstable structure Patient with 10% of normal activity Enough to generate NADPH under normal condition Newly made RBCs have normal 6PDH activity Patients recover quickly (8 days)